Cargando…

Introduction of Triple-Drug Therapy for Accelerating Lymphatic Filariasis Elimination in India: Lessons Learned

There are 670 million people at risk of contracting lymphatic filariasis (LF) in India, which bears 40% of the global burden of the disease. The National Program to Eliminate LF was launched in 2004 first with a single-drug therapy—diethylcarbamazine (DEC), followed by a two-drug therapy—DEC + alben...

Descripción completa

Detalles Bibliográficos
Autores principales: Tripathi, Bhupendra, Roy, Nupur, Dhingra, Neeraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154644/
https://www.ncbi.nlm.nih.gov/pubmed/35292580
http://dx.doi.org/10.4269/ajtmh.21-0964